https://www.taxtmi.com/news?id=33064 Medidata expands its clinical development platform with AI-powered innovations, synthetic data, and virtual twins to simulate patient cohorts, reduce exposure to experimental therapies, and improve trial performance. The company integrates biosensor-derived patient data to build comprehensive virtual representations of individuals and care journeys, supports digital therapeutics and Virtual + Real treatment approaches, and leverages its large patient-level historical clinical trial data set and industry partnerships to accelerate study design, execution, and lifelong patient engagement. en-us Thu, 06 Feb 2025 11:01:03 +0530 Thu, 06 Feb 2025 11:01:03 +0530 TaxTMI RSS Generator https://www.taxtmi.com/news?id=33064 Medidata expands its clinical development platform with AI-powered innovations, synthetic data, and virtual twins to simulate patient cohorts, reduce exposure to experimental therapies, and improve trial performance. The company integrates biosensor-derived patient data to build comprehensive virtual representations of individuals and care journeys, supports digital therapeutics and Virtual + Real treatment approaches, and leverages its large patient-level historical clinical trial data set and industry partnerships to accelerate study design, execution, and lifelong patient engagement. News - Thu, 06 Feb 2025 11:01:03 +0530 https://www.taxtmi.com/news?id=33064